拜耳集团Bayer AG (BAYZF) 2006年年度报告「OTC」.pdf

1、Science For A Better Life Bayer Annual Report 2006 Bayer:Science For A Better Life is more than a corporate slogan.Its a call to action.A truly ambitious goal.A claim that demands to be vindicated every day,and that essentially means one thing:striving for improvement.The images on the opening pages

2、 of this Annual Report contain impressive examples of how the inventor company Bayer justifi es that claim with products and services that enhance the quality of life.But research never stops.The companys scientists are constantly on the track of innovations to address future challenges.And it is th

3、is that defi nes the fascination of Bayer.Cover picture Invigorating drug discovery:following Bayers successful acquisition of Schering AG,Berlin,Germany,the two companies researchers have joined forces in the search for new drugs.The picture shows two Bayer Schering Pharma scien-tists Dr.Ulrike Fuh

4、rmann,formerly of Schering,and Dr.Thomas Krmer,for-merly of Bayer Pharmaceuticals meeting for an exchange of views.In the back-ground is a laboratory at the research center in Wuppertal,Germany.Bayer Group Key Data20052006Change million million%Bayer Group Net sales24,70128,956+17.2EBITDA14,1224,675

5、+13.4EBITDA before special items4,6025,584+21.3EBIT22,5142,762+9.9EBIT before special items3,0473,479+14.2Income before income taxes1,9121,980+3.6Net income1,5971,683+5.4Earnings per share()32.192.22+1.4Gross cash fl ow43,1143,913+25.7Net cash fl ow53,2273,928+21.7Capital expenditures1,2101,739+43.7

6、Research and development expenses1,7292,297+32.9Dividend per Bayer AG share()0.951.00+5.3Bayer HealthCareNet external sales7,99611,724+46.6EBITDA11,2801,947+52.1EBITDA before special items1,4872,613+75.7EBIT29231,313+42.3EBIT before special items1,1771,715+45.7Gross cash fl ow49231,720+86.3Net cash